Clinical trials
Phase 2 Carcinoma, Ovarian Epithelial trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
| Active, not recruiting | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xiaoxiang Chen | 2 |
| First Affiliated Hospital of Harbin Medical University | 1 |
| Lei Li | 1 |
| Peking Union Medical College Hospital | 1 |
| Peking University Third Hospital | 1 |
| RemeGen Co., Ltd. | 1 |
| Shandong University | 1 |
| Shanghai Gynecologic Oncology Group | 1 |
| Shenzhen SiBiono GeneTech Co.,Ltd | 1 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 15 |
| Ovarian Neoplasms | 7 |
| Fallopian Tube Neoplasms | 6 |
| Carcinoma | 3 |
| Genital Diseases, Female | 3 |
| Genital Neoplasms, Female | 3 |
| Neoplasms by Histologic Type | 3 |
| Neoplasms by Site | 3 |
| Neoplasms, Glandular and Epithelial | 3 |
| Ovarian Diseases | 3 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.